Significance of NS3 and NS5 antigens in screening for HCV antibody
Authors:
- K VernelenKVK Vernelen
- H ClaeysHCH Claeys
- H VerhaertHVH Verhaert
- A VolckaertsAVA Volckaerts
- C VermylenCVC Vermylen
- Anne-Marie CourouceACAnne-Marie Courouce
- Françoise BouchardeauFBFrançoise Bouchardeau
- Annie GiraultAGAnnie Girault
- NadineLe MarrecNMNadineLe Marrec
- Eric GoffinEGEric Goffin
- Yves PirsonYPYves Pirson
- Chantal CornuCCChantal Cornu
- 1 April 1994
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 343 (8901) , 853-854
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Evaluation of indeterminate c22‐3 reactivity in volunteer blood donorsTransfusion, 1994
- Outcome of HCV infection after renal transplantationKidney International, 1994
- Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective studyKidney International, 1993
- Indeterminate hepatitis CThe Lancet, 1993
- Third‐Generation Recombinant Immunoblot Assay to Confirm Hepatitis C Virus‐Indeterminate Serological SamplesVox Sanguinis, 1993
- A pattern of 5‐1‐1 and c100‐3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donorsTransfusion, 1993
- Evaluation of anti-HCV capsid indeterminate serum samplesThe Lancet, 1992